AtriCure Inc. (ATRC) PT Lowered to $55 at UBS
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $47.27 -0.71%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
UBS analyst Danielle Antalffy lowered the price target on AtriCure Inc. (NASDAQ: ATRC) to $55.00 (from $60.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Yeti Holdings Inc. (YETI) PT Raised to $49 at Morgan Stanley
- SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
